We are live on ! Find out more
CA

Callahan Advisors Portfolio holdings

AUM $1.33B
1-Year Est. Return 29.71%
This Fund
S&P 500
This Quarter Est. Return
-1.94%
1 Year Est. Return
+29.71%
3 Year Est. Return
+87.75%
5 Year Est. Return
+121.89%
10 Year Est. Return
+408.77%
AUM
$796M
AUM Growth
-$26.8M
Cap. Flow
-$2.58M
Cap. Flow %
-0.32%
Top 10 Hldgs %
33.24%
Holding
141
New
8
Increased
58
Reduced
61
Closed
1

Top Buys

Rank Stock Value
1
MA icon
Mastercard
MA
+$4.93M
2
LLY icon
Eli Lilly
LLY
+$3.48M
3
BKNG icon
Booking.com
BKNG
+$1.75M
4
DHI icon
D.R. Horton
DHI
+$1.73M
5
DY icon
Dycom Industries
DY
+$1.43M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$2.93M
2
DIS icon
Walt Disney
DIS
+$2.91M
3
T icon
AT&T
T
+$2.64M
4
DLTR icon
Dollar Tree
DLTR
+$2.46M
5
CVS icon
CVS Health
CVS
+$2.29M

Sector Composition

Rank Sector Weight
1 Technology 17.54%
2 Healthcare 14.51%
3 Financials 12.75%
4 Consumer Discretionary 10.61%
5 Energy 10.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IFF icon
76
International Flavors & Fragrances
IFF
$20.2B
$1.91M 0.24%
28,055
+255
+0.9% +$18.6K
ENB icon
77
Enbridge
ENB
$119B
$1.82M 0.23%
54,212
-820
-1% -$29.1K
TJX icon
78
TJX Companies
TJX
$174B
$1.74M 0.22%
19,618
+1,983
+11% +$175K
QSR icon
79
Restaurant Brands International
QSR
$25.7B
$1.67M 0.21%
25,030
– –
GD icon
80
General Dynamics
GD
$104B
$1.59M 0.2%
7,208
-299
-4% -$66.1K
FIS icon
81
Fidelity National Information Services
FIS
$23.1B
$1.34M 0.17%
24,300
– –
HD icon
82
Home Depot
HD
$331B
$1.33M 0.17%
4,414
+21
+0.5% +$6.75K
K
83
DELISTED
Kellanova
K
$1.3M 0.16%
23,289
– –
DY icon
84
Dycom Industries
DY
$12B
$1.28M 0.16%
+14,380
New +$1.43M
BMY icon
85
Bristol-Myers Squibb
BMY
$133B
$1.28M 0.16%
22,017
-47,818
-68% -$2.93M
VZ icon
86
Verizon
VZ
$195B
$1.13M 0.14%
34,794
-2,273
-6% -$76.8K
GSK icon
87
GSK
GSK
$104B
$1.12M 0.14%
+30,875
New +$1.1M
FE icon
88
FirstEnergy
FE
$28B
$1.11M 0.14%
32,600
– –
ZTS icon
89
Zoetis
ZTS
$32.4B
$1.09M 0.14%
6,288
-168
-3% -$30.5K
FISV
90
Fiserv Inc
FISV
$28.8B
$1.07M 0.14%
9,515
-1,800
-16% -$222K
RTX icon
91
RTX Corp
RTX
$290B
$1.05M 0.13%
14,520
+870
+6% +$74.5K
COP icon
92
ConocoPhillips
COP
$147B
$1.04M 0.13%
8,661
+279
+3% +$32.4K
LMT icon
93
Lockheed Martin
LMT
$134B
$1.03M 0.13%
2,519
-296
-11% -$131K
NTRS icon
94
Northern Trust
NTRS
$33.3B
$1.03M 0.13%
14,824
+3,888
+36% +$294K
FANG icon
95
Diamondback Energy
FANG
$57.1B
$972K 0.12%
6,273
+987
+19% +$146K
GIS icon
96
General Mills
GIS
$19.1B
$948K 0.12%
14,815
– –
SBUX icon
97
Starbucks
SBUX
$120B
$924K 0.12%
10,128
+3,265
+48% +$320K
SCHB icon
98
Schwab US Broad Market ETF
SCHB
$43.9B
$837K 0.11%
50,376
+546
+1% +$9.45K
NVDA icon
99
NVIDIA
NVDA
$4.86T
$801K 0.1%
18,420
+2,980
+19% +$134K
PARA
100
DELISTED
Paramount Global Class B
PARA
$792K 0.1%
61,370
– –
2 3
4
5 6

Similar funds

SWM
SHP Wealth Management Plymouth, Massachusetts $1.33B AUM
MRL
Mantle Ridge LP New York $1.33B AUM 11.36% 1-Year Est. Return
HCM
Hilton Capital Management Garden City, New York $1.32B AUM 15.59% 1-Year Est. Return
CRAM
Compass Rose Asset Management New York $1.33B AUM 2.38% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
MDSL
M.D. Sass LLC New York $1.32B AUM 16.01% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Callahan Advisors's Q3 2023 Portfolio in Review

As of Q3 2023, Callahan Advisors held 141 positions worth $796M, down 3.3% from $823M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Callahan Advisors's Q3 2023 filing shows 8 new, 58 increased, 61 reduced and 1 closed positions. Its largest new stake was Mastercard: 12,272 shares worth $4.86M. The largest sale was Bristol-Myers Squibb, an estimated $2.93M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.

  • Callahan Advisors's largest Q3 2023 buy was Mastercard: 12,272 shares worth $4.86M.
  • Callahan Advisors added most to Eli Lilly in Q3 2023, an estimated $3.48M increase.
  • Callahan Advisors's biggest Q3 2023 reduction was Bristol-Myers Squibb, cutting an estimated $2.93M.
  • Callahan Advisors fully exited Schwab US TIPS ETF in Q3 2023, selling an estimated $322K.
  • Callahan Advisors's ten largest holdings make up 33% of its $796M portfolio in Q3 2023.
  • Callahan Advisors opened 8 new positions and closed 1 in Q3 2023.
  • Callahan Advisors's portfolio value fell 3.3% quarter-over-quarter to $796M.

Based on Callahan Advisors's 13F filing for Q3 2023, filed 23 Oct 2023.